€41M for a Rising Star of Synthetic Biology: Ginkgo Bioworks

03/08/2015 - 2 minutes

Once will not hurt, we’ll speak a bit about an inspiring US-based company. A synthetic biology start-up from the worlds biggest biocluster is on its road to success. Shortly after its Series A, Boston-based Ginkgo Bioworks goes on better and raises $45M (€41M). The microbe engineer makes food taste moreish and perfume smell better. And it has big plans to spend the money!

Ginkgo Bioworks was founded in 2008 by the godfather of synthetic biology Tom Knight as well as MIT biological engineer school graduates Jason Kelly, Reshma Shetty, Barry Canton and Austin Che. The company pictures itself as the intersection of industrial design and biology. To produce cultured ingredients such as flavors, fragrances, cosmetics and sweeteners, Ginkgo has its proprietary software to design customized microbes.  This happens in Biowork1, the company’s Boston-based ‘foundry’, in which Ginkgos in-built robotics streamline the design, construction, and testing of engineered organisms.

Ginkgo currently designs more than 20 stated organisms for sundry customers including Fortune 500 companies. Among these are organic pesticides for an agriculture company,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!